Results 161 to 170 of about 27,163 (253)

External validation of the budget impact analysis of the drug fingolimode in the treatment of multiple sclerosis. [PDF]

Cost Eff Resour Alloc
Campello CRS, da Costa MGS, Pinto M.
europepmc   +1 more source

Tumefactive Multiple Sclerosis Lesions Under Fingolimod Treatment [PDF]

, 2012
Linssen, W.H.J.P., Oosten, B.W. van, Pouwels, P.J.W., Visser, F., Wattjes, M.P.   +4 more
core   +1 more source

Gender differences in safety issues during Fingolimod therapy: Evidence from a real‐life Relapsing Multiple Sclerosis cohort [PDF]

, 2017
Alessia Manni, Vita Direnzo, Antonio Iaffaldano, Valentina Di Lecce, Carla Tortorella, Stefano Zoccolella, Pietro Iaffaldano, María Trojano, Damiano Paolicelli   +8 more
openalex   +1 more source

The efficacy and safety of fingolimod in patients with relapsing multiple sclerosis: A meta‐analysis

, 2019
Ting Yang, Xin Tian, Chaoyang Chen, Ling‐Yun Ma, Shuang Zhou, Min Li, Ye Wu, Ying Zhou, Yimin Cui   +8 more
openalex   +2 more sources

Case Report: Hemorrhagic Vasculitis in a Patient With Multiple Sclerosis Receiving Fingolimod. [PDF]

Clin Case Rep
Zeynali Esfahani F, Payere M, Karimikhoshnoudian B, Baghaei M, Nahayati M.   +4 more
europepmc   +1 more source

Peripheral Blood T Cell Dynamics Predict Relapse in Multiple Sclerosis Patients on Fingolimod

, 2015
Zi-Ye Song, Ryo Yamasaki, Yuji Kawano, Shinya Sato, Katsuhisa Masaki, Satoshi Yoshimura, Dai Matsuse, Hiroyuki Murai, Takuya Matsushita, Jun‐ichi Kira   +9 more
openalex   +2 more sources

057 Real world evidence (RWE) on long-term persistence of fingolimod in relapsing-remitting multiple sclerosis (RRMS) in australia

, 2018
Robert Walker, Mark R. Schulz, Birendra Arora, Eric Chung, Prabhjot Juneja, S Verhaeghe, Tim Spelman, Simon Broadley   +7 more
openalex   +2 more sources

Successful Treatment of Progressive Multifocal Leukoencephalopathy With Tenofovir Alafenamide Fumarate. [PDF]

Neurol Neuroimmunol Neuroinflamm
Torkildsen Ø, Bru ANS, Behzadi GIN, Myhr KM.   +3 more
europepmc   +1 more source

Macular oedema and changes in macular thickness in multiple sclerosis patients treated with fingolimod [PDF]

, 2019
Thomas Lohne Nørgaard, Carl Uggerhøj Andersen, Claudia Hilt, Charlotte Uggerhøj Andersen   +3 more
openalex   +1 more source

Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model

, 2022
Niloofar Najarzadegan, Mahboobeh Madani, Masoud Etemadifar, Nahad Sedaghat   +3 more
openalex   +1 more source